rs3731684
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021815.5(SLC5A7):c.741+18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,595,768 control chromosomes in the GnomAD database, including 10,120 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1471 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8649 hom. )
Consequence
SLC5A7
NM_021815.5 intron
NM_021815.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.325
Publications
5 publications found
Genes affected
SLC5A7 (HGNC:14025): (solute carrier family 5 member 7) This gene encodes a sodium ion- and chloride ion-dependent high-affinity transporter that mediates choline uptake for acetylcholine synthesis in cholinergic neurons. The protein transports choline from the extracellular space into presynaptic terminals for synthesis into acetylcholine. Increased choline uptake results from increased density of this protein in synaptosomal plasma membranes in response to depolarization of cholinergic terminals. Dysfunction of cholinergic signaling has been implicated in various disorders including depression, attention-deficit disorder, and schizophrenia. An allelic variant of this gene is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
SLC5A7 Gene-Disease associations (from GenCC):
- neuronopathy, distal hereditary motor, type 7AInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- congenital myasthenic syndrome 20Inheritance: AR Classification: STRONG Submitted by: G2P, Ambry Genetics, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- distal hereditary motor neuropathy type 7Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-108002058-C-T is Benign according to our data. Variant chr2-108002058-C-T is described in ClinVar as Benign. ClinVar VariationId is 261429.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.130 AC: 19724AN: 152080Hom.: 1464 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
19724
AN:
152080
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.123 AC: 29596AN: 241268 AF XY: 0.113 show subpopulations
GnomAD2 exomes
AF:
AC:
29596
AN:
241268
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.104 AC: 150273AN: 1443570Hom.: 8649 Cov.: 30 AF XY: 0.101 AC XY: 72435AN XY: 715574 show subpopulations
GnomAD4 exome
AF:
AC:
150273
AN:
1443570
Hom.:
Cov.:
30
AF XY:
AC XY:
72435
AN XY:
715574
show subpopulations
African (AFR)
AF:
AC:
5822
AN:
32836
American (AMR)
AF:
AC:
10309
AN:
42364
Ashkenazi Jewish (ASJ)
AF:
AC:
1382
AN:
25418
East Asian (EAS)
AF:
AC:
5298
AN:
39374
South Asian (SAS)
AF:
AC:
2827
AN:
83702
European-Finnish (FIN)
AF:
AC:
6952
AN:
53288
Middle Eastern (MID)
AF:
AC:
241
AN:
5650
European-Non Finnish (NFE)
AF:
AC:
111527
AN:
1101310
Other (OTH)
AF:
AC:
5915
AN:
59628
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
5724
11448
17173
22897
28621
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4288
8576
12864
17152
21440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.130 AC: 19765AN: 152198Hom.: 1471 Cov.: 32 AF XY: 0.130 AC XY: 9685AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
19765
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
9685
AN XY:
74418
show subpopulations
African (AFR)
AF:
AC:
7211
AN:
41512
American (AMR)
AF:
AC:
2863
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
182
AN:
3470
East Asian (EAS)
AF:
AC:
751
AN:
5168
South Asian (SAS)
AF:
AC:
186
AN:
4830
European-Finnish (FIN)
AF:
AC:
1448
AN:
10594
Middle Eastern (MID)
AF:
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6643
AN:
68010
Other (OTH)
AF:
AC:
244
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
891
1782
2673
3564
4455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
346
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Sep 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neuronopathy, distal hereditary motor, type 7A;C4310694:Congenital myasthenic syndrome 20 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.